Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2007

01-07-2007 | Original Paper

Coping with HIV Treatment Side Effects: Conceptualization, Measurement, and Linkages

Authors: Mallory O. Johnson, Torsten B. Neilands

Published in: AIDS and Behavior | Issue 4/2007

Login to get access

Abstract

Side effects from HIV treatments impact quality of life (QOL) and adherence to care, and influence decisions about health care. The purposes of this study are to describe the development of a measure of coping with HIV treatment side effects, the SECope, and to provide support for the reliability and validity of the measure. Based in Stress and Coping Theory, the 20-item measure assesses strategies for coping with HIV treatment side effects, and includes scales of Positive Emotion Focused Coping, Social Support Seeking, Nonadherence, Information Seeking, and Taking Side Effect Medications. The factor structure was supported by exploratory and confirmatory factor analyses with two samples of HIV+ individuals on treatment (Ns = 173 and 233). The SECope has demonstrated reliability (internal consistency and test–retest), and its validity is supported through construct and criterion-referenced analyses. Nonadherence as a strategy for coping with side effects was associated with poorer provider relations, lower treatment knowledge, and higher beliefs of treatment effectiveness. Findings have the potential to inform investigations and interventions in the context of treatment of HIV disease and other medical conditions.
Appendix
Available only for authorised users
Literature
Allen, M. J., & Yen, W. M. (1979). Introduction to measurement theory. Monterey, Calif.: Brooks/Cole Pub. Co.
Ammassari, A., Murri, R., Pezzotti, P., Trotta, M., Ravisio, L., & DeLonis, P. (2001). Self reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445–449.PubMed
Beck, A. T. (1967). Depression: Causes and treatment. Philadelphia, PA: University of Pennsylvania Press.
Beck, A. T., & Steer, R. A. (1984). Internal consistencies of the original and revised Beck Depression Inventory. Journal of Clinical Psychology, 40, 1365–1367.PubMedCrossRef
Bentler, P. M., & Bonnett, D. G. (1980). Significance tests and goodness of fit in the analysis of covariance structures. Psychological Bulletin, 88, 588–606.CrossRef
Binik, Y. M., Chowanec, G. D., & Devins, G. M. (1990). Marital role strain, illness intrusiveness, and their impact on marital and individual adjustment in end-stage renal disease. Psychology & Health, 4, 245–257.
Breitbart, W., McDonald, M. V., Rosenfeld, B., Monkman, N. D., & Passik, S. (1998). Fatigue in ambulatory AIDS patients. Journal of Pain & Symptom Management, 15, 159–167.CrossRef
Browne, M. W., & Cudek, R. (1993). Alternative ways of assessing model fit. In K. A. Bollen & J. S. Long (Eds.), Testing structural equation models. Newbury Park, CA: Sage Publications.
Chene, G., May, M., Costagliola, D., Monforte, A. d. A., Junghans, C., Wolf, F. d., et al. (2002). Prognosis of HIV-1 infected drug naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration. Paper presented at the XIV International AIDS Conference, Barcelona.
Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clinical Infectious Diseases, 30(Suppl 2), S171–S176.PubMedCrossRef
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255–266.PubMedCrossRef
Chesney, M. A., Neilands, T. B., Chambers, D. B., Taylor, J. M., & Folkman, S. (2006). A validity and reliability study of the coping self-efficacy scale. British Journal of Health Psychology, 11, 421–437.PubMedCrossRef
Comrey, A. L. (1973). A first course in factor analysis. New York: Academic Press.
Cutrona, C. E. (1989). Ratings of social support by adolescents and adult informants: Degree of correspondence and prediction of depressive symptoms. Journal of Personality & Social Psychology, 57, 723–730.CrossRef
Cutrona, C. E., & Russell, D. W. (1990). Type of social support and specific stress: Toward a theory of optimal matching. In B. R. Sarason & I. G. Sarason (Eds.), Social support: An interactional view (pp. 319–366). New York: Wiley.
D’Zurilla, T. J., Nezu, A. M., & Maydeu-Olivares, A. (2002). Social problem solving inventory-revised. North Tonoawanda, NY: Multi-health Systems.
Devins, G. M. (1983). The emotional impact of end-stage renal disease: Importance of patients’ perceptions of intrusiveness and control. International Journal of Psychiatry in Medicine, 13, 327–343.PubMedCrossRef
Devins, G. M., Armstrong, S. J., Mandin, H., & Paul, L. C. (1990). Recurrent pain, illness intrusiveness, and quality of life in end-stage renal disease. Pain, 42, 279–285.PubMedCrossRef
Devins, G. M., Mandin, H., Hons, R. B., & Burgess, E. D. (1990). Illness intrusiveness and quality of life in end-stage renal disease: Comparison and stability across treatment modalities. Health Psychology, 9, 117–142.PubMedCrossRef
Elliott, T. R., Johnson, M. O., & Jackson, R. (1997). Social problem solving and health behaviors of undergraduate students. Journal of College Student Development, 38, 24–31.
Flora, D. B., & Curran, P. J. (2004). An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychological Methods, 9, 466–491.PubMedCrossRef
Foddy, W. H. (1993). Constructing questions for interviews and questionnaires: Theory and practice in social research. New York, USA.
Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: a review of published and abstract reports [Review]. Patient Education & Counseling, 46, 93–108.CrossRef
Grady, C., Anderson, R., & Chase, G. A. (1998). Fatigue in HIV-infected men receiving investigational interleukin-2. Nursing Research, 47, 227–234.PubMedCrossRef
Griffin, K. W., & Rabkin, J. G. (1997). Psychological distress in people with HIV/AIDS: Prevalence rates and methodological issues. AIDS & Behavior, 1, 29–42.CrossRef
Groopman, J. E. (1998). Fatigue in cancer and HIV/AIDS. Oncology, 12, 335–344; discussion 345–336.PubMed
Horne, R., Weinman, J., & Hankins, M. (1999). The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14, 1–24.
Hu, L.-t., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1–55.
Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E. D., et al. (2003). Theory guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Healthy Living Project. AIDS Patient Care STDS, 17, 645–656.PubMedCrossRef
Johnson, M. O., Charlebois, E., Morin, S. F., Catz, S. L., Goldstein, R. B., Remien, R. H., et al. (2005). Perceived Adverse Effects of Antiretroviral Therapy. Journal of Pain & Symptom Management, 29, 193–205.CrossRef
Johnson, M. O., Chesney, M., Goldstein, R. B., Remien, R. H., Catz, S., Gore-Felton, C., et al. (2006). Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV infected adults: A mediation model. AIDS Patient Care & STDS, 20, 258–268.CrossRef
Johnson, M. O., Elliott, T. R., Neilands, T. B., Morin, S. F., & Chesney, M. A. (2006). A social problem solving model of adherence to HIV medications. Health Psychology, 25, 355–363.PubMedCrossRef
Johnson, M. O., & Folkman, S. (2004). Side effect and disease related symptom representations among HIV+ adults on antiretroviral therapy. Psychology, Health & Medicine, 9, 139–148.CrossRef
Johnson, M. O., Stallworth, T., & Neilands, T. B. (2003). The drugs or the disease? Causal attributions of symptoms held by HIV positive adults on HAART. AIDS and Behavior, 7, 109–117.PubMedCrossRef
Johnson, S. C., & Gerber, J. G. (2000). Advances in HIV/AIDS therapy. Advances in Internal Medicine, 45, 1–40.PubMed
Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer Pub. Co.
Lorenz, K. A., Shapiro, M. F., Asch, S. M., Bozzette, S. A., & Hays, R. D. (2001). Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Annals of Internal Medicine, 134, 854–860.PubMed
Maes, S., Leventhal, H., & de Ridder, D. T. D. (1996). Coping with chronic diseases. In E. Moshe Zeidner, E. Norman S. Endler, & et al. (Eds.), Handbook of coping: Theory, research, applications (pp. 221–251). New York, USA: John Wiley.
Millsap, R. E., & Yun-Tein, J. (2004). Assessing factorial invariance in ordered-categorical measures. Multivariate Behavioral Research, 39, 479–516.CrossRef
Muthén, B., du Toit, S. H. C., & Spisic, D. (in press). Robust Inference using weighted least squares and quadratic estimating equations in latent variable modeling with categorical and continuous outcomes. Psychometrika.
Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes, 36, 1100–1102.PubMedCrossRef
Raykov, T. (1997). Estimation of composite reliability for congeneric measures. Applied Psychological Measurement, 21, 173–184.CrossRef
Raykov, T., & Shrout, P. E. (2002). Reliability of scales with general structure: Point and interval estimation using a structural equation modeling approach. Structural Equation Modeling, 9, 195–212.CrossRef
Russell, D. W., & Cutrona, C. E. (1991). Social support, stress, and depressive symptoms among the elderly: Test of a process model. Psychology & Aging, 6, 190–210.
Spector, P. E. (1992). Summated rating scale construction: An introduction. Newbury Park, CA, USA.
Stall, R., Hoff, C., Coates, T., Paul, J., Phillips, K., Ekstrand, M., et al. (1996). Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: Implications for secondary prevention efforts. Journal of Acquired Immune Deficiency Syndromes, 11, 151–160.
Stirratt, M. J., Remien, R. H., Smith, A., Copeland, O. Q., Dolezal, C., & Krieger, D. (2006). The role of HIV serostatus disclosure in antiretroviral adherence. AIDS & Behavior, 10, 483–493.CrossRef
Treisman, G. J., & Kaplin, A. I. (2002). Neurologic and psychiatric complications of antiretroviral agents. AIDS, 16, 1201–1215.PubMedCrossRef
Volberding, P. A. (2003). HIV therapy in 2003: Consensus and controversy. AIDS, 17(Suppl 1) S4–S11.PubMed
Walsh, J. C., Mandalia, S., & Gazzard, B. G. (2002). Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS, 16, 269–277.PubMedCrossRef
Walsh, J. C., Pozniak, A. L., Nelson, M. R., Mandalia, S., & Gazzard, B. G. (2002). Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance. Journal of Acquired Immune Deficiency Syndromes, 30, 278–287.PubMed
Watson, A., Samore, M. H., & Wanke, C. A. (1996). Diarrhea and quality of life in ambulatory HIV-infected patients. Digestive Diseases and Sciences, 41, 1794–1800.PubMedCrossRef
Metadata
Title
Coping with HIV Treatment Side Effects: Conceptualization, Measurement, and Linkages
Authors
Mallory O. Johnson
Torsten B. Neilands
Publication date
01-07-2007
Published in
AIDS and Behavior / Issue 4/2007
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-007-9229-4

Other articles of this Issue 4/2007

AIDS and Behavior 4/2007 Go to the issue

Original Paper

A Daily Web Diary of the Sexual Experiences of Men who have Sex with Men: Comparisons with a Retrospective Recall Survey

Original Paper

Development and Psychometric Evaluation of a Self-administered Questionnaire to Measure Knowledge of Sexually Transmitted Diseases

Original Paper

Barebacking, the Internet, and Harm Reduction: An Intercept Survey with Gay and Bisexual Men in Los Angeles and New York City

Original Paper

Correlates and Predictors of Women’s Sex Trading Over Time among a Sample of Out-of-treatment Drugs Abusers

Review Paper

Conducting Internet-Based HIV/STD Prevention Survey Research: Considerations in Design and Evaluation

Original Paper

Prevalence and Correlates of Sexual Behaviors Among Karen Villagers in Northern Thailand
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits